Lv7
4950 积分 2022-12-29 加入
PROTAC targeted protein degraders: the past is prologue
26天前
已完结
PROTACs: past, present and future
26天前
已完结
Methods to Study the Molecular Mechanism and Drive the Design of Protein Degraders
27天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
2个月前
已完结
Rational Design of Dual Degraders by Incorporating Molecular Glue Structural Features into PROTAC Degraders
5个月前
已完结
Formation of pyrimido[1,2-b]pyridazines, a new bicyclic triazaheterocyclic system
11个月前
已关闭
Enantioselective synthesis of (2S,2′R)-erythro-methylphenidate
11个月前
已完结
Design and Evaluation of Phosphonamidate-Linked Exatecan Constructs for Highly Loaded, Stable, and Efficacious Antibody–Drug Conjugates
11个月前
已完结
皖公网安备34019202002308
